Professor Cornelia van Duijn
Colleges
Cornelia van Duijn
Professor of Epidemiology
Cornelia van Duijn is Professor of Epidemiology at Oxford Population Health and Fellow of St Cross College, Oxford, and co-leads the HDR UK Oxford Region.
Her research within the Oxford Big Data Institute focuses on large-scale –omics studies of neurodegenerative disorders including Alzheimer, Parkinson and Creutzfeldt–Jakob disease and ophthalmological disorders including glaucoma, age-related macular degeneration and myopia.
She further studies systemic vascular, endocrine and gastrointestinal pathology that is relevant for brain and ocular function. Her current research portfolio includes cross-omics research integrating (epi)genetic, transcriptomic, proteomic, metabolomic and microbiome data of epidemiological cohorts with state of the art brain imaging and cellular model systems.
Over the years, Cornelia has been a leading figure in several international consortia including ENGAGE (European Network for Genetic and Genomic Epidemiology), CHARGE (Cohorts for Heart & Aging Research in Genome Epidemiology), IGAP (International Genetics of Alzheimer Disease Project, ADSP (Alzheimer Disease Sequencing Project) and IGGC (International Genetics of Glaucoma Consortium).
At present, she is the leader of two major consortia: the Horizon2020 CoSTREAM consortium aiming to understand the link between stroke and Alzheimer disease and the MEMORABEL Gut-Brain consortium aiming to unravel the role of the gut microbiome in Alzheimer disease and brain pathology.
She further leads the human proteomics and metabolomics discovery research in the Innovative Medicine Initiative (IMI) ADAPTED programme, which aims to identify new Alzheimer medicines through understanding the function of the APOE gene. Cornelia is a member of the Royal Netherlands Academy of Arts and Sciences (KNAW) and the Netherlands Council for Medical Sciences (RMW).
Cornelia studied Human Nutrition and Mathematical Statistics at the Agricultural University of Wageningen and Genetics and Epidemiology at the Erasmus University Medical School.
Recent publications
-
HMG-CoA reductase is a potential therapeutic target for migraine: a mendelian randomization study
Journal article
Qu K. et al, (2024), Scientific Reports, 14
-
Brain Care Score and Neuroimaging Markers of Brain Health in Asymptomatic Middle-Age Persons.
Journal article
Rivier CA. et al, (2024), Neurology, 103
-
Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations.
Journal article
Argentieri MA. et al, (2024), Nat Med
-
Association of neuroticism with incident dementia, neuroimaging outcomes, and cognitive function.
Journal article
Gao Y. et al, (2024), Alzheimers Dement
-
Plasma trimethylamine N-oxide (TMAO): associations with cognition, neuroimaging, and dementia.
Journal article
Yaqub A. et al, (2024), Alzheimers Res Ther, 16